Pharmaceutical Composition for Treating Scars on the Skin, and Method for Treating Scars on the Skin Using Same
Abstract
The present invention relates to a pharmaceutical composition for treating scars on the skin, comprising a mixture of botulinum toxin and air. The mixture of botulinum toxin and air according to the present invention, when injected in the dermis, may temporarily removed the elasticity of the dermis and flatten out the depressed part of the scar, and thus enables elaborate intradermic resection and increases the therapeutic effects of lasers for treating pulsed dye laser or of fractional lasers. Thus, scars on the skin can be effectively improved through a one-time operation without negatively affecting the daily lives of patients.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for treating atrophic skin scars, comprising a mixture of botulinum toxin serotype A or B and air mixed in a volume ratio of 1:1 to 1:10.
2 - 3 . (canceled)
4 . The pharmaceutical composition of claim 1 , wherein the composition is used for pretreatment of subcision.
5 . The pharmaceutical composition of claim 1 , wherein the composition removes the elasticity of the dermis.
6 . The pharmaceutical composition of claim 1 , wherein the composition is formulated in the form of aerosol.
7 - 11 . (canceled)Join the waitlist — get patent alerts
Track US2016106653A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.